Katrin Palk

612 total citations
13 papers, 384 citations indexed

About

Katrin Palk is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Katrin Palk has authored 13 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Katrin Palk's work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Katrin Palk is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Katrin Palk collaborates with scholars based in Estonia, Sweden and Denmark. Katrin Palk's co-authors include Mats Heyman, Jonas Abrahamsson, Heléne Hallböök, Thomas Leth Frandsen, Kim Vettenranta, Laimonas Griškevičius, Kjeld Schmiegelow, Goda Vaitkevičienė, Petter Quist‐Paulsen and Henrik Birgens and has published in prestigious journals such as Blood, Leukemia and Journal of Internal Medicine.

In The Last Decade

Katrin Palk

11 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin Palk Estonia 6 325 233 159 79 65 13 384
Anna Berg Netherlands 7 348 1.1× 247 1.1× 228 1.4× 66 0.8× 24 0.4× 9 465
Ramya Ramanujachar United Kingdom 5 251 0.8× 228 1.0× 97 0.6× 48 0.6× 87 1.3× 9 319
Pui Ch United States 6 216 0.7× 145 0.6× 94 0.6× 28 0.4× 28 0.4× 7 301
Juan-José Ortega Spain 7 368 1.1× 214 0.9× 239 1.5× 80 1.0× 42 0.6× 10 436
Denise M Oliansky United States 9 283 0.9× 83 0.4× 379 2.4× 150 1.9× 7 0.1× 10 497
Monika Brüggemann Germany 8 240 0.7× 106 0.5× 135 0.8× 126 1.6× 20 0.3× 16 297
Louise Tram Henriksen Denmark 8 144 0.4× 147 0.6× 20 0.1× 35 0.4× 56 0.9× 17 241
Simone Reinmuth Germany 8 294 0.9× 219 0.9× 37 0.2× 55 0.7× 23 0.4× 9 377
R. Rutledge United States 4 270 0.8× 131 0.6× 212 1.3× 77 1.0× 6 0.1× 12 345
Rosa Rendtorff Germany 7 219 0.7× 155 0.7× 36 0.2× 29 0.4× 17 0.3× 8 290

Countries citing papers authored by Katrin Palk

Since Specialization
Citations

This map shows the geographic impact of Katrin Palk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Palk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Palk more than expected).

Fields of papers citing papers by Katrin Palk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Palk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Palk. The network helps show where Katrin Palk may publish in the future.

Co-authorship network of co-authors of Katrin Palk

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Palk. A scholar is included among the top collaborators of Katrin Palk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Palk. Katrin Palk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Genell, Anna, Katrin Palk, Valdas Pečeliūnas, et al.. (2023). Upfront Autologous Stem Cell Transplantation in Myeloma Patients >65 Years: A Population-Based Study from the Nordic Myeloma Study Group. Blood. 142(Supplement 1). 4729–4729. 1 indexed citations
3.
Hallböök, Heléne, Mats Heyman, Ulla Wartiovaara‐Kautto, et al.. (2023). Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia. Acta Oncologica. 62(12). 1723–1731. 1 indexed citations
4.
Quist‐Paulsen, Petter, N. Toft, Mats Heyman, et al.. (2019). T-cell acute lymphoblastic leukemia in patients 1–45 years treated with the pediatric NOPHO ALL2008 protocol. Leukemia. 34(2). 347–357. 38 indexed citations
5.
Toft, N., Henrik Birgens, Jonas Abrahamsson, et al.. (2017). Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia. Leukemia. 32(3). 606–615. 263 indexed citations
6.
Toft, N., Henrik Birgens, Jonas Abrahamsson, et al.. (2016). Adults And Children (1-45 Years) With Ph-Negative All Have Almost Identical Outcome In Risk-Stratified Analysis Of Nopho All2008. Haematologica. 101. 35–35. 5 indexed citations
7.
Hulegårdh, Erik, Erik Holmberg, Katrin Palk, et al.. (2016). Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years. Acta Haematologica. 136(3). 167–173.
8.
Toft, Nina, Henrik Birgens, Jonas Abrahamsson, et al.. (2015). Toxicity profile and treatment delays in NOPHO ALL2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemia. European Journal Of Haematology. 96(2). 160–169. 55 indexed citations
9.
10.
Wennström, Lovisa, Soodabeh Safai‐Kutti, Dick Stockelberg, et al.. (2011). The Incidence and Survival of Acute de novo Leukemias in Estonia and in a Well-Defined Region of Western Sweden during 1997–2001: A Survey of Patients Aged 16–64 Years. Acta Haematologica. 126(3). 176–185. 3 indexed citations
11.
Palk, Katrin, Krista Vaht, Hele Everaus, et al.. (2010). The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997–2001: A survey of patients aged ≥65 years. Cancer Epidemiology. 34(1). 24–28. 3 indexed citations
12.
Palk, Katrin, Hele Everaus, Tiiu Aareleid, et al.. (2004). The incidence and survival of acute de novo leukaemias in Estonia and in a well‐defined region of western Sweden during 1982–1996: a survey of patients aged ≥65 years. Journal of Internal Medicine. 256(1). 79–85. 7 indexed citations
13.
Wennström, Lovisa, Soodabeh Safai‐Kutti, Dick Stockelberg, et al.. (2004). The Incidence and Survival of AcuteDe NovoLeukaemias in Estonia and in a Well Defined Region of Western Sweden During 1982 – 1996: A Survey of Patients Aged 16 – 64 Years. Leukemia & lymphoma. 45(5). 915–921. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Berg Breakdown of academic impact, for papers by Ramya Ramanujachar Breakdown of academic impact, for papers by Pui Ch Breakdown of academic impact, for papers by Juan-José Ortega Breakdown of academic impact, for papers by Denise M Oliansky Breakdown of academic impact, for papers by Monika Brüggemann Breakdown of academic impact, for papers by Louise Tram Henriksen Breakdown of academic impact, for papers by Simone Reinmuth Breakdown of academic impact, for papers by R. Rutledge Breakdown of academic impact, for papers by Rosa Rendtorff
Rankless by CCL
2026